|
08 Jan 2026 |
Jyothy Labs
|
Consensus Share Price Target
|
266.35 |
364.67 |
- |
36.91 |
buy
|
|
|
|
|
13 Nov 2025
|
Jyothy Labs
|
Axis Direct
|
266.35
|
320.00
|
309.85
(-14.04%)
|
20.14 |
Hold
|
|
|
Considering the near-term challenges, we maintain our HOLD rating on the stock and revise our TP to Rs 320/share. The TP implies an upside potential of 3% from the CMP.
|
|
13 Nov 2025
|
Jyothy Labs
|
ICICI Securities Limited
|
266.35
|
400.00
|
309.85
(-14.04%)
|
50.18 |
Buy
|
|
|
JYL’s Q2FY26 performance was impacted by GST-led disruption and pricing/grammage adjustments (value/volume growth of 0.4%/2.8% YoY).
|
|
12 Nov 2025
|
Jyothy Labs
|
Motilal Oswal
|
266.35
|
350.00
|
310.10
(-14.11%)
|
31.41 |
Neutral
|
|
|
Jyothy Laboratories (JYL) posted flat YoY sales growth in 2QFY26, with volumes rising 3% (est. 4%; 1QFY26 4%). The difference between value and volume growth was primarily due to MRP reductions, higher grammage, and promotional price-offs in select categories.
|
|
22 Aug 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
266.35
|
412.00
|
340.65
(-21.81%)
|
54.68 |
Buy
|
|
|
JLL delivered a modest Q1FY26 performance amid a challenging demand environ- Gross margin contracted 280bps YoY to 48.5%, due to input cost pressures and heightened competition in the Dish wash segment. EBITDA margin stood at 16.5%,...
|
|
13 Aug 2025
|
Jyothy Labs
|
Axis Direct
|
266.35
|
355.00
|
329.30
(-19.12%)
|
33.28 |
Hold
|
|
|
Considering the near-term challenges, we have downgraded the stock from BUY to HOLD and revised our TP to Rs 355/share, implying an upside potential of 7% from the CMP.
|
|
13 Aug 2025
|
Jyothy Labs
|
ICICI Securities Limited
|
266.35
|
430.00
|
329.30
(-19.12%)
|
61.44 |
Buy
|
|
|
JYL’s Q1FY26 performance was subdued with revenue/ volume growth of 1.4%/ 3.6% YoY impacted by heightened competitive intensity across segments.
|
|
27 May 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
266.35
|
404.00
|
341.50
(-22.01%)
|
51.68 |
Accumulate
|
|
|
|
|
21 May 2025
|
Jyothy Labs
|
Sharekhan
|
266.35
|
395.00
|
338.75
(-21.37%)
|
48.30 |
Buy
|
|
|
Q4FY25 was yet another muted quarter for JLL amid subdued demand and higher competitive intensity hit revenue growth, while inflation in key input prices impacted profitability.
|
|
12 May 2025
|
Jyothy Labs
|
Motilal Oswal
|
266.35
|
375.00
|
350.80
(-24.07%)
|
Target met |
Neutral
|
|
|
Jyothy Laboratories (JYL) reported 1% YoY sales growth (below our est.) in 4QFY25. Volume growth was 4% (est. 7%, 8% in 3QFY25). The gap between volume and value growth was due to higher grammage and promotional price subs in select categories.
|
|
12 Apr 2025
|
Jyothy Labs
|
Axis Direct
|
266.35
|
405.00
|
371.50
(-28.30%)
|
52.06 |
Buy
|
|
|
We recommend a BUY with a near-term TP of Rs 405, implying an upside of 10% from the CMP.
|
|
11 Mar 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
266.35
|
395.00
|
333.90
(-20.23%)
|
Target met |
Buy
|
|
|
|
|
01 Feb 2025
|
Jyothy Labs
|
Axis Direct
|
266.35
|
450.00
|
415.70
(-35.93%)
|
68.95 |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
31 Jan 2025
|
Jyothy Labs
|
Sharekhan
|
266.35
|
490.00
|
398.40
(-33.15%)
|
83.97 |
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q3FY25 performance was muted with revenue growing by just 4%, while a ~110 bps y-o-y decline in OPM led to 4% y-o-y decline in PAT.
|
|
04 Dec 2024
|
Jyothy Labs
|
Geojit BNP Paribas
|
266.35
|
496.00
|
411.15
(-35.22%)
|
|
Buy
|
|
|
|
|
13 Nov 2024
|
Jyothy Labs
|
Axis Direct
|
266.35
|
500.00
|
436.10
(-38.92%)
|
|
Buy
|
|
|
With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
12 Nov 2024
|
Jyothy Labs
|
Motilal Oswal
|
266.35
|
500.00
|
441.35
(-39.65%)
|
Target met |
Neutral
|
|
|
Jyothy Laboratories (JYL) reported flat sales YoY (miss) in 2QFY25. It posted a five-year CAGR of 10%. Volume growth was at 3%, on account of a high base.
|
|
12 Nov 2024
|
Jyothy Labs
|
Sharekhan
|
266.35
|
575.00
|
441.35
(-39.65%)
|
|
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q2FY2025 performance was muted with revenue and PAT remaining flat y-o-y. OPM at 18.9% rose by 38 bps y-o-y.
|
|
13 Aug 2024
|
Jyothy Labs
|
Geojit BNP Paribas
|
266.35
|
645.00
|
548.10
(-51.40%)
|
|
Accumulate
|
|
|
|
|
26 Jul 2024
|
Jyothy Labs
|
Axis Direct
|
266.35
|
600.00
|
548.45
(-51.44%)
|
|
Buy
|
|
|
We maintain our long-term BUY rating on the stock.
|
|
25 Jul 2024
|
Jyothy Labs
|
Sharekhan
|
266.35
|
655.00
|
547.70
(-51.37%)
|
|
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q1FY2025 operating performance was in line with our expectation with revenues growing by 8% (versus expectation of 8.5%) while OPM stood at 18% (versus expectation of 17.9%).
|